News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Jordi Remon: We had efficacy data on ADCs after osimertinib and PD in EGFR-mutant NSCLC
Jordi Remon/X
Mar 26, 2025, 17:42

Jordi Remon: We had efficacy data on ADCs after osimertinib and PD in EGFR-mutant NSCLC

Jordi Remon, Cancer Specialist at CIOCC Barcelona, shared on X:

“We had efficacy data ADCs after osi-PD in EGFRm NSCLC. Today good mPFS (9.5-11.7) with Osi+DatopotamAb Dxd after osi-PD. Data looks promising than chemo+Amiv. Better protection maintaining osi? Biomarker for dato? Toxicity is imp. Future trial: osi-DATOD vs Ami-CT?”

cancer CIOCC Jordi Remon OncoDaily Oncology
Special Coverage
Blog
Mar 29, 2025, 23:14
Join us live for the Open Plenary Session: Common Sense Oncology
Insight
Mar 29, 2025, 23:04
Naveen Pemmaraju: Polycythemia vera: past, present and future
Insight
Mar 29, 2025, 21:34
Elvina Almuradova: Pembrolizumab plus CRT as the New Standard in Locally Advanced Cervical Cancer
Blog
Mar 29, 2025, 21:16
Shivani Modi: Honored to present 3 posters at ASCO and 5 published abstracts
Blog
Mar 29, 2025, 20:53
We’re Back for the Jimmy Fund Walk 2025: Florez Lab
Blog
Mar 29, 2025, 20:49
We hosted an engaging panel at eMerge Americas - Sylvester Comprehensive Cancer Center
Blog
Mar 29, 2025, 20:40
In 2024, the AACR Grants Program distributed more than $8 million to support 50 meritorious research projects
Blog
Mar 29, 2025, 20:35
Sakhr Alshwayyat: Our abstracts have been accepted for presentation and publication at ASCO 2025
Blog
Mar 29, 2025, 20:30
Hil Moss: Fun to be in DC today for the National Coalition for Cancer Survivorship Cancer Policy Roundtable
Blog
Mar 29, 2025, 20:24
Amy C. Moore: Learn and share about the growing importance of these little circles of DNA in tumor development
Blog
Mar 29, 2025, 20:20
Benjamin L. Ebert: We know the importance and impact of having access to the best cancer treatment
Blog
Mar 29, 2025, 20:20
Patrick Hwu: Inhibiting MDK could be a valuable strategy to improve immunotherapy outcomes in melanoma